Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 9:12:1478517.
doi: 10.3389/fbioe.2024.1478517. eCollection 2024.

Alternatives of mesenchymal stem cell-derived exosomes as potential therapeutic platforms

Affiliations
Review

Alternatives of mesenchymal stem cell-derived exosomes as potential therapeutic platforms

Sihun Lee et al. Front Bioeng Biotechnol. .

Abstract

With outstanding therapeutic potential in the tissue regeneration and anti-inflammation, mesenchymal stem cell-derived exosomes (MSC-EXOs) have emerged as a prominent therapeutic in recent. However, poor production yield and reproducibility have remained as significant challenges of their practical applications. To surmount these challenges, various alternative materials with stem cell-like functions, have been recently investigated, however, there has been no comprehensive analysis in these alternatives so far. Here, we discuss the recent progress of alternatives of MSC-EXOs, including exosomes and exosome-like nanovesicles from various biological sources such as plants, milk, microbes, and body fluids. Moreover, we extensively compare each alternative by summarizing their unique functions and mode of actions to suggest the expected therapeutic target and future directions for developing alternatives for MSC-EXOs.

Keywords: exosomes; extracellular vesicles; membrane vesicles; nanovesicles; regenerative medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Representative examples of alternative exosomes or exosome-like nanovesicles and their potential therapeutic targets (Illustrated by S. Y. Jung by using Microsoft PowerPoint).

Similar articles

Cited by

References

    1. Adil M., Filimban F. Z., Ambrin A., Quddoos A., Sher A. A., Naseer M. (2024). Phytochemical screening, HPLC analysis, antimicrobial and antioxidant effect of Euphorbia parviflora L. (Euphorbiaceae Juss.). Sci. Rep. 14 (1), 5627. 10.1038/s41598-024-55905-w - DOI - PMC - PubMed
    1. Admyre C., Johansson S. M., Qazi K. R., Filen J. J., Lahesmaa R., Norman M., et al. (2007). Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 179 (3), 1969–1978. 10.4049/jimmunol.179.3.1969 - DOI - PubMed
    1. Agrawal A. K., Aqil F., Jeyabalan J., Spencer W. A., Beck J., Gachuki B. W., et al. (2017). Milk-derived exosomes for oral delivery of paclitaxel. Nanomed 13 (5), 1627–1636. 10.1016/j.nano.2017.03.001 - DOI - PubMed
    1. Ahn S., Siddiqi M. H., Aceituno V. C., Simu S. Y., Yang D. C. (2016). Suppression of MAPKs/NF-κB activation induces intestinal anti-inflammatory action of ginsenoside Rf in HT-29 and RAW264.7 cells. Immunol. Invest. 45 (5), 439–449. 10.3109/08820139.2016.1168830 - DOI - PubMed
    1. Ahn S. H., Ryu S. W., Choi H., You S., Park J., Choi C. (2022). Manufacturing therapeutic exosomes: from bench to industry. Mol. Cells 45 (5), 284–290. 10.14348/molcells.2022.2033 - DOI - PMC - PubMed

LinkOut - more resources